✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Balaxi Pharmaceuticals Ltd.

BALAXI

Market Cap
₹322 Cr.
P/E
11.78

Balaxi Pharmaceuticals Ltd.

  • Balaxi Pharma.
  • Trident Lifeline
  • Fredun Pharma
FAQs on Balaxi Pharmaceuticals Ltd. Shareprice

Balaxi Pharma. has given lower returns compared to its competitors.
Balaxi Pharma. has grown at ~-25.98% over the last 2yrs while peers have grown at a median rate of 39.11%

Balaxi Pharma. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Balaxi Pharma. is 11.78, while 3 year average PE is 10.29.
Also latest EV/EBITDA of Balaxi Pharma. is 7.64 while 3yr average is 11.29.

View FAQ's On Business
Growth Table
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Balance Sheet
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Cash Flow
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Quarterly Results
  • Balaxi Pharmaceuticals Ltd.
  • Trident Lifeline
  • Fredun Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Balaxi Pharmaceuticals Ltd. Financials

Balance sheet of Balaxi Pharma. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Balaxi Pharma. is increasing.
Latest debt of Balaxi Pharma. is -₹30.54 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹105.14 Crs.

The profit is oscillating.
The profit of Balaxi Pharma. is ₹27.36 Crs for TTM, -₹7.31 Crs for Mar 2024 and ₹51.74 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Balaxi Pharma. latest dividend payout ratio is 1.04% and 3yr average dividend payout ratio is 1.04%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech